Yang CT - Search Results

1

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.

Tung PH, Chiu TH, Huang AC, Ju JS, Huang CH, Wang CC, Ko HW, Chung FT, Hsu PC, Fang YF, Guo YK, Kuo CS, Yang CT. Tung PH, et al. Among authors: yang ct. Ther Adv Med Oncol. 2024 Jan 19;16:17588359231222604. doi: 10.1177/17588359231222604. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38249338 Free PMC article.

2

Erlotinib treatment in patients with advanced lung adenocarcinoma with CISH-positive and CISH-negative EGFR gene alterations.

Hou MM, Huang SF, Kuo HP, Yang CT, Tsai YH, Yu CT, Lin HC, Chen CH, Wang CL, Chung FT, Hsieh JJ, Hsu T, Cheng HY, Ou LY, Wang HM, Lin YC, Chang NJ, Chang JW. Hou MM, et al. Among authors: yang ct. Anticancer Res. 2012 Mar;32(3):1107-12. Anticancer Res. 2012. PMID: 22399641

3

Levels of circulating microparticles in lung cancer patients and possible prognostic value.

Tseng CC, Wang CC, Chang HC, Tsai TH, Chang LT, Huang KT, Leu S, Yen CH, Liu SF, Chen CH, Yang CT, Yip HK, Lin MC. Tseng CC, et al. Among authors: yang ct. Dis Markers. 2013;35(5):301-10. doi: 10.1155/2013/715472. Epub 2013 Sep 15. Dis Markers. 2013. PMID: 24167378 Free PMC article.

4

Chronic obstructive pulmonary disease in stage I non-small cell lung cancer that underwent anatomic resection: the role of a recurrence promoter.

Kuo CH, Wu CY, Lee KY, Lin SM, Chung FT, Lo YL, Liu CY, Hsiung TC, Yang CT, Wu YC. Kuo CH, et al. Among authors: yang ct. COPD. 2014 Aug;11(4):407-13. doi: 10.3109/15412555.2013.838946. Epub 2014 Jan 29. COPD. 2014. PMID: 24475998

5

Circulating endothelial-derived activated microparticle: a useful biomarker for predicting one-year mortality in patients with advanced non-small cell lung cancer.

Wang CC, Tseng CC, Hsiao CC, Chang HC, Chang LT, Fang WF, Leu S, Wang YH, Tsai TH, Yang CT, Chen CH, Yip HK, Ho CK, Lin MC. Wang CC, et al. Among authors: yang ct. Biomed Res Int. 2014;2014:173401. doi: 10.1155/2014/173401. Epub 2014 Jun 29. Biomed Res Int. 2014. PMID: 25061601 Free PMC article. Clinical Trial.

6

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations.

Chiu CH, Yang CT, Shih JY, Huang MS, Su WC, Lai RS, Wang CC, Hsiao SH, Lin YC, Ho CL, Hsia TC, Wu MF, Lai CL, Lee KY, Lin CB, Yu-Wung Yeh D, Chuang CY, Chang FK, Tsai CM, Perng RP, Chih-Hsin Yang J. Chiu CH, et al. Among authors: yang ct. J Thorac Oncol. 2015 May;10(5):793-799. doi: 10.1097/JTO.0000000000000504. J Thorac Oncol. 2015. PMID: 25668120 Free article.

7

Overall response to first-line tyrosine kinase inhibitor and second-line chemotherapy is predictive of survival outcome in epidermal growth factor receptor-mutated adenocarcinoma.

Kuo SC, Hsu PC, Chen CH, Yu CT, Wang CL, Chung FT, Lin SM, Lo YL, Chen TC, Liu CY, Yang CT. Kuo SC, et al. Among authors: yang ct. Chemotherapy. 2014;60(3):201-10. doi: 10.1159/000371735. Chemotherapy. 2014. PMID: 25871639

8

Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention.

Tseng CC, Wang CC, Hsiao CC, Lu HI, Leu S, Chang HC, Huang KT, Fang WF, Chen YM, Liu SF, Yang CT, Lin MC, Yip HK. Tseng CC, et al. Among authors: yang ct. Tumour Biol. 2016 Sep;37(9):11873-11882. doi: 10.1007/s13277-016-5047-5. Epub 2016 Apr 8. Tumour Biol. 2016. PMID: 27059732

9

Continuous epidermal growth factor receptor-tyrosine kinase inhibitor administration in primary lung adenocarcinoma patients harboring favorable mutations with controlled target lung tumors dose not hinder survival benefit despite small new lesions.

Hsu PC, Chiu LC, Li SH, Chen CH, Wang CL, Kao KC, Chang JW, Wang CW, Yu CT, Chung FT, Yang CT, Liu CY. Hsu PC, et al. Among authors: yang ct. Biomed J. 2016 Apr;39(2):121-9. doi: 10.1016/j.bj.2015.07.002. Epub 2016 Jun 9. Biomed J. 2016. PMID: 27372167 Free PMC article.

10

YAP promotes erlotinib resistance in human non-small cell lung cancer cells.

Hsu PC, You B, Yang YL, Zhang WQ, Wang YC, Xu Z, Dai Y, Liu S, Yang CT, Li H, Hu B, Jablons DM, You L. Hsu PC, et al. Among authors: yang ct, yang yl. Oncotarget. 2016 Aug 9;7(32):51922-51933. doi: 10.18632/oncotarget.10458. Oncotarget. 2016. PMID: 27409162 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

653 results

Search Page